3-deoxy-glycero-pentos-2-ulose: derived form poly(ADP-ribosyl)histones [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 277989 |
| SCHEMBL ID | 8364556 |
| MeSH ID | M0138487 |
| Synonym |
|---|
| 4,5-dihydroxy-2-oxopentanal |
| 3-deoxyxylosone |
| nsc 127076 |
| pentanal, 4,5-dihydroxy-2-oxo-, (s)- |
| 3-deoxy-2-pentulose |
| 3-deoxy-glycero-pentos-2-ulose |
| 3-deoxypentosulose |
| 6815-38-9 |
| nsc-127076 |
| nsc127076 |
| SCHEMBL8364556 |
| 3-deoxy-d-xylose |
| 1ST3269 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.57) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||